MARIA CALZADA: Open Payments
NPI 1508960824 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 61 payments from 10 companies in 2025. Trend: 2023 $24 · 2024 $145 · 2025 $1,250
Food & beverage: $1,250
| Company | Payments | Amount |
|---|---|---|
| Cumberland Pharmaceuticals, Inc. | 25 | $354 |
| ViiV Healthcare Company | 10 | $249 |
| ABBVIE INC. | 15 | $184 |
| MIMEDX Group, Inc. | 1 | $126 |
| Esperion Therapeutics, Inc. | 1 | $102 |
| Paratek Pharmaceuticals, Inc. | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $59 |
| EMD Serono, Inc. | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Smith+Nephew, Inc. | 1 | $24 |
Products named: VIBATIV, DOVATO, NEXLETOL, NUZYRA, EMBLAVEO, AVYCAZ, Kerendia, CABENUVA.
Industry payments across TX — which companies pay providers there.
